A detailed history of O'Shaughnessy Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, O'Shaughnessy Asset Management, LLC holds 214,166 shares of ABBV stock, worth $35.3 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
214,166
Previous 180,316 18.77%
Holding current value
$35.3 Million
Previous $30.9 Million 36.75%
% of portfolio
0.39%
Previous 0.33%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $5.55 Million - $6.75 Million
33,850 Added 18.77%
214,166 $42.3 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $2.1 Million - $2.46 Million
13,590 Added 8.15%
180,316 $30.9 Million
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $4.6 Million - $5.24 Million
28,786 Added 20.87%
166,726 $30.4 Million
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $690,614 - $777,794
5,019 Added 3.78%
137,940 $21.4 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $4.15 Million - $4.81 Million
31,093 Added 30.53%
132,921 $19.8 Million
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $4.79 Million - $5.96 Million
-36,127 Reduced 26.19%
101,828 $13.7 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $992,892 - $1.14 Million
-6,866 Reduced 4.74%
137,955 $22 Million
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $2.27 Million - $2.72 Million
16,408 Added 12.78%
144,821 $23.4 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $2.88 Million - $3.31 Million
21,485 Added 20.09%
128,413 $17.2 Million
Q2 2022

Aug 11, 2022

BUY
$137.62 - $174.96 $2.76 Million - $3.51 Million
20,056 Added 23.09%
106,928 $16.4 Million
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $5.65 Million - $7.01 Million
42,795 Added 97.09%
86,872 $14.1 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $1.79 Million - $2.27 Million
16,673 Added 60.84%
44,077 $5.97 Million
Q3 2021

Nov 10, 2021

BUY
$106.4 - $120.78 $34,792 - $39,495
327 Added 1.21%
27,404 $2.96 Million
Q2 2021

Aug 09, 2021

BUY
$105.21 - $117.21 $16,728 - $18,636
159 Added 0.59%
27,077 $3.05 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $423,010 - $465,683
4,135 Added 18.15%
26,918 $2.91 Million
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $238,411 - $321,880
2,962 Added 14.94%
22,783 $2.44 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $463,742 - $544,280
-5,398 Reduced 21.4%
19,821 $1.74 Million
Q2 2020

Aug 13, 2020

SELL
$73.37 - $98.18 $10.3 Million - $13.8 Million
-140,658 Reduced 84.8%
25,219 $2.48 Million
Q1 2020

May 13, 2020

SELL
$64.5 - $97.79 $5.02 Million - $7.62 Million
-77,906 Reduced 31.96%
165,877 $12.6 Million
Q4 2019

Feb 12, 2020

SELL
$72.13 - $90.25 $3.84 Million - $4.81 Million
-53,302 Reduced 17.94%
243,783 $21.6 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $832,028 - $1 Million
13,211 Added 4.65%
297,085 $22.5 Million
Q2 2019

Aug 07, 2019

BUY
$65.7 - $83.98 $2.82 Million - $3.6 Million
42,890 Added 17.8%
283,874 $20.6 Million
Q1 2019

May 10, 2019

BUY
$77.14 - $90.79 $1.44 Million - $1.69 Million
18,639 Added 8.38%
240,984 $0
Q4 2018

Feb 12, 2019

BUY
$77.85 - $96.01 $14.5 Million - $17.9 Million
186,312 Added 517.06%
222,345 $20.5 Million
Q3 2018

Nov 06, 2018

BUY
$88.91 - $98.84 $3.19 Million - $3.54 Million
35,829 Added 17563.24%
36,033 $3.41 Million
Q2 2018

Aug 10, 2018

SELL
$89.78 - $106.23 $2.15 Million - $2.54 Million
-23,957 Reduced 99.16%
204 $19,000
Q1 2018

May 08, 2018

SELL
$92.01 - $123.21 $2.75 Million - $3.68 Million
-29,844 Reduced 55.26%
24,161 $2.29 Million
Q4 2017

Feb 13, 2018

SELL
$89.56 - $98.21 $1.58 Million - $1.74 Million
-17,688 Reduced 24.67%
54,005 $5.22 Million
Q3 2017

Nov 13, 2017

SELL
$69.85 - $89.22 $4.01 Million - $5.12 Million
-57,374 Reduced 44.45%
71,693 $6.37 Million
Q2 2017

Aug 14, 2017

BUY
N/A
129,067
129,067 $9.36 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.